Immune regulation in multiple myeloma: the host–tumour conflict
- 1 September 1999
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 13 (3) , 151-162
- https://doi.org/10.1054/blre.1999.0111
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- Clinical significance of the determination of angiogenic factorsEuropean Journal Of Cancer, 1996
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- Interleukin‐10 induces interleukin‐11 responsiveness in human myeloma cell linesFEBS Letters, 1995
- T-cell activation: integration of signals from the antigen receptor and costimulatory moleculesImmunology Today, 1995
- Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of diseaseEuropean Journal Of Cancer, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Generation of T cell clones binding F(ab′)2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathyCancer Immunology, Immunotherapy, 1991
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- The costimulatory function of antigen-presenting cellsImmunology Today, 1990
- Inflammatory and immunomodulatory roles of TGF-βImmunology Today, 1989